Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Grimwade

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Plos One|September 27, 2016
Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid LeukemiaNaeem Khan, Robert K Hills, Steve Knapper, et al.
Leukemia & Lymphoma|August 26, 2017
Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyLicia Iaccarino, Tiziana Ottone, Syed Khizer Hasan, et al.
Leukemia|February 6, 2021
Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesisRichard Dillon, Matthew J Ahearne, Lynn Quek, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemiaFabien Guidez, Sarah Parks, Henna Wong, et al.
Blood|August 18, 2005
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemiaRosemary E Gale, Robert Hills, Arnold R Pizzey, et al.
Genes, Chromosomes & Cancer|January 1, 2003
Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemiaAndreas Reiter, Susanne Saussele, David Grimwade, et al.
Genes, Chromosomes & Cancer|November 22, 2008
Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocationTiziana Ottone, Syed Khizer Hasan, Enrico Montefusco, et al.
The Lancet. Oncology|September 19, 2015
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trialAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Blood Cancer Journal|August 1, 2018
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemiaMiriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, et al.
Blood Cancer Journal|March 2, 2019
Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemiaMiriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Plos One|September 27, 2016
Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid LeukemiaNaeem Khan, Robert K Hills, Steve Knapper, et al.
Leukemia & Lymphoma|August 26, 2017
Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyLicia Iaccarino, Tiziana Ottone, Syed Khizer Hasan, et al.
Leukemia|February 6, 2021
Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesisRichard Dillon, Matthew J Ahearne, Lynn Quek, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemiaFabien Guidez, Sarah Parks, Henna Wong, et al.
Blood|August 18, 2005
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemiaRosemary E Gale, Robert Hills, Arnold R Pizzey, et al.
Genes, Chromosomes & Cancer|January 1, 2003
Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemiaAndreas Reiter, Susanne Saussele, David Grimwade, et al.
Genes, Chromosomes & Cancer|November 22, 2008
Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocationTiziana Ottone, Syed Khizer Hasan, Enrico Montefusco, et al.
The Lancet. Oncology|September 19, 2015
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trialAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Blood Cancer Journal|August 1, 2018
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemiaMiriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, et al.
Blood Cancer Journal|March 2, 2019
Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemiaMiriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, et al.
Pageof 11